e-learning
resources
Milan 2017
Tuesday, 12.09.2017
CAP: severity scores, risk groups and biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
ONE YEAR MORTALITY IN PATIENTS WITH PNEUMOCOCCAL BACTERAEMIC COMMUNITY ACQUIRED PNEUMONIA: ROLE OF THREE PNEUMONIA SEVERITY SCORES
L. Serrano Fernandez (Bilbao (Bizkaia), Spain)
Source:
International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Session:
CAP: severity scores, risk groups and biomarkers
Session type:
Thematic Poster
Number:
4097
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Serrano Fernandez (Bilbao (Bizkaia), Spain). ONE YEAR MORTALITY IN PATIENTS WITH PNEUMOCOCCAL BACTERAEMIC COMMUNITY ACQUIRED PNEUMONIA: ROLE OF THREE PNEUMONIA SEVERITY SCORES. 4097
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
LYMPHOPENIA AS PREDICTOR OF LONG TERM MORTALITY IN PATIENTS WITH HOSPITAL ACQUIRED PNEUMONIA
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018
MICROBIAL ETIOLOGY OF COMMUNITY ACQUIRED PNEUMONIA: 13-YEAR PROSPECTIVE STUDY
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
PREDICTING THE MORTALITY OF PNEUMONIA PATIENTS VISITING THE EMERGENCY DEMARTMENT THROUGH MACHINE LEARNING
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
A STUDY OF CLINICORADIOLOGICAL AND MICROBIOLOGICAL PROFILE AND BIOMARKERS IN CASES OF COMMUNITY ACQUIRED PNEUMONIA ADMITTED IN A TERTIARY CARE HOSPITAL
Source: Virtual Congress 2021 – Pneumonia
Year: 2021
FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
DIFFERENCES IN HOSPITAL COURSE IN COMMUNITY ACQUIRED PNEUMONIA (CAP) ACCORDING TO ANTIBIOTIC TREATMENT
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
RISK FACTORS FOR LONG-TERM MORTALITY IN PATIENTS WITH PNEUMOCOCCAL COMMUNITY-ACQUIRED PNEUMONIA
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
LONG –TERM MORTALITY IN PATIENTS WITH PNEUMOCOCCAL AND LEGIONELLA PNEUMONIA
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
AWAKE PRONE POSITION IN CRITICAL AND SEVERE COVID-19 PATIENTS UNDERGOING NONINVASIVE RESPIRATORY SUPPORT: A RETROSPECTIVE MULTICENTER COHORT STUDY.
Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19
Year: 2021
FOLLOW-UP OF PATIENTS WITH SEVERE COVID-19 PNEUMONIA AND TORPID EVOLUTION
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
PREVALENCE AND CHARACTERISTICS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ADMITTED FOR PNEUMONIA ACQUIRED IN THE COMMUNITY.
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020
PHYSIOLOGICAL EFFECTS OF THREE DIFFERENT VENTILATORY MODES IN PATIENTS WITH OBESITY HYPOVENTILATION SYNDROME UNDER NOCTURNAL NONINVASIVE VENTILATION: A PILOT RANDOMIZED STUDY
Source: International Congress 2017 – Noninvasive ventilation for chronic respiratory failure
Year: 2017
DEVELOPMENT OF A DIGITAL TELEREHABILITATION SOLUTION: ANALYSIS OF THE NEEDS OF PATIENTS WITH CHRONIC DISEASES
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017
PERINATAL INFLAMMATION AND INTRAUTERINE GROWTH RETARDATION ARE BOTH ASSOCIATED WITH LUNG FUNCTION IMPAIRMENT AT 12 YEARS OF AGE IN VERY PRETERM INFANTS
Source: International Congress 2018 – Assessing pathophysiology in children
Year: 2018
EFFICACY OF A BUNDLE FOR PREVENTION OF VENTILATOR ASSOCIATED PNEUMONIA IN AN ADULT INTENSIVE CARE UNIT
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020
IMPACT OF A COMMUNITY-BASED EXERCISE PROGRAM ON PULMONARY FUNCTION IN MIDDLE-AGE AND OLDER PATIENTS WITH TYPE 2 DIABETES
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017
THE IMPACT OF PULMONARY REHABILITATION ON PHYSICAL ACTIVITY AND PHYSICAL FITNESS LEVELS IN LUNG TRANSPLANT CANDIDATES; PRELIMINARY STUDY RESULTS
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017
THE IMPACT OF REFLEXOLOGY AND HOMEOPATHY ADDED TO CONVENTIONAL ASTHMA TREATMENT ON MARKERS OF AIRWAY INFLAMMATION– A RANDOMISED STUDY
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
NON BACTERIEMIC PNEUMOCOCCAL PNEUMONIA: GENERAL CHARACTERISTICS AND PREDISPOSING FACTORS FOR POOR OUTCOME
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept